JPS58180486A - 5-phenyloxy-1-phenyl-1h-pyrazolo(3,4-b)pyrazine derivative - Google Patents

5-phenyloxy-1-phenyl-1h-pyrazolo(3,4-b)pyrazine derivative

Info

Publication number
JPS58180486A
JPS58180486A JP6367682A JP6367682A JPS58180486A JP S58180486 A JPS58180486 A JP S58180486A JP 6367682 A JP6367682 A JP 6367682A JP 6367682 A JP6367682 A JP 6367682A JP S58180486 A JPS58180486 A JP S58180486A
Authority
JP
Japan
Prior art keywords
group
phenyl
formula
pyrazolo
phenyloxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6367682A
Other languages
Japanese (ja)
Inventor
Shinichi Suzuki
鈴木 紳一
Hiromitsu Honda
本多 宏光
Kunitomo Suzuki
鈴木 国友
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lion Corp
Original Assignee
Lion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lion Corp filed Critical Lion Corp
Priority to JP6367682A priority Critical patent/JPS58180486A/en
Priority to US06/428,016 priority patent/US4460773A/en
Priority to DE19823237243 priority patent/DE3237243A1/en
Publication of JPS58180486A publication Critical patent/JPS58180486A/en
Pending legal-status Critical Current

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

NEW MATERIAL:A compound shown by the formula I (R is phenyl or phenyl whose one or more H are replaced with halogen, OH, lower alkyl, lower alkoxy, amino, or lower alkylamide) EXAMPLE:5-Phenyloxy-1-phenyl-1H-pyrazolo[3,4-b]pyrazine. USE:An antitumor agent. PROCESS:A 5-halogenophenyl-1-phenyl-1H-pyrazolo[3,4-b]pyrazine shown by the formula II[X is halogen, SO2-R group, NO2 group, CN group (R is alkyl, phenyl, or alkylphenyl)] is reacted with a phenol derivative shown by the formula III, to give a compound shown by the formula I .

Description

【発明の詳細な説明】 (但し、Rはフェニル基又はその水素原子の1又は2以
上金ハロダン原子、水酸基、低級アルキル基、低級アル
コキシ基、アミン基もしくは低級アルキルアミド基によ
り置換されたフェニル基金示す。) で示される新規5−フェニルオキシ−1−フェニルーI
Hーピラゾロ[ 3.4 − b 〕ビラノン誘導体に
関する。
Detailed Description of the Invention (However, R is a phenyl group or a phenyl group substituted with one or more of its hydrogen atoms by a gold-halodane atom, a hydroxyl group, a lower alkyl group, a lower alkoxy group, an amine group, or a lower alkylamide group) ) Novel 5-phenyloxy-1-phenyl I represented by
The present invention relates to H-pyrazolo[3.4-b]bilanone derivatives.

従来より、抗腫瘍作用を有する種々の物質が開発され、
提案芒れているが、本発明者らも抗腫瘍作用に優れ、抗
腫瘍剤として好適に使用することができる化合物につき
鋭意研究を行なっているうち、5−クロロー1−フェニ
ル−IH−ピラゾロC 3,4 − b ) ヒラノン
全フ□ノール誘導体と反応させる等の方法により、前記
(1)式で示される新規化合物5−フェニルオキノー1
−フェニル−]H−ピラゾロC3,4−1) 〕ピラノ
ン誘導体が得られると共に、これらの化合物が優れた抗
腫瘍作用を有し、抗腫瘍剤として効果的に使用され得る
ことを知見し、本発明をなすVこ至った。
Conventionally, various substances with antitumor effects have been developed.
Although there are many proposals, the present inventors have been conducting intensive research on compounds that have excellent antitumor effects and can be suitably used as antitumor agents. 3,4-b) The novel compound 5-phenyloquino 1 represented by the above formula (1) is produced by a method such as reacting with a hylanone total phenol derivative.
-Phenyl-]H-pyrazoloC3,4-1)]pyranone derivatives can be obtained, and we have discovered that these compounds have excellent antitumor effects and can be effectively used as antitumor agents, and we have developed this invention. V came up with an invention.

以下、本発明につき更に詳しく説明する。The present invention will be explained in more detail below.

本発明に係る新規化合物5−フェニルオキシ−1−フェ
ニル−I H−ピラゾロ(3,4−b )ビリノン誘導
体は、上述した(1)式、即ち(但し、Rはフェニル基
又はその水素原子の1又は2以上をフッ素、塩素、臭素
、ヨウ素といったハロダン原子、水酸基、低級アルキル
基、低級アルコキシ基、アミン基もしくは低級アルキル
アミド基により置換されたフェニル基金示す。) で示される化学構造式金石するものである。
The novel compound 5-phenyloxy-1-phenyl-I H-pyrazolo(3,4-b)bilinone derivative according to the present invention has the above-mentioned formula (1) (where R is a phenyl group or a hydrogen atom thereof). A phenyl group substituted with one or more halodane atoms such as fluorine, chlorine, bromine, or iodine, a hydroxyl group, a lower alkyl group, a lower alkoxy group, an amine group, or a lower alkylamide group. It is something.

ここで、(1)式において、低級アルキル基としては、
メチル基、エチル基、プロピル基、イソプロピル基、ブ
チル基、イソブチル基、ペンチル基、イソペンチル基、
ネオペンチル基等の炭素数1〜6の直鎖又は分枝鎖のも
のが挙けられる。
Here, in formula (1), the lower alkyl group is:
Methyl group, ethyl group, propyl group, isopropyl group, butyl group, isobutyl group, pentyl group, isopentyl group,
Examples include linear or branched chains having 1 to 6 carbon atoms, such as a neopentyl group.

また、低級アルコキシ基としては、メトキシ基、エトキ
シ基、ノロポキシ基、ブトキシ基、ペンチルオキシ基、
ヘキシルオキシ基等の炭素数1〜6の直鎖又は分枝鎖の
ものが挙げられる。
In addition, examples of lower alkoxy groups include methoxy group, ethoxy group, noropoxy group, butoxy group, pentyloxy group,
Examples include straight or branched chains having 1 to 6 carbon atoms such as hexyloxy groups.

更に、低級アルキルアミド基としては、アセトアミド基
、!ロピオンアミド基、n−ブチルアミド基等の炭素数
1〜6の直鎖又は分枝鎖のものが挙げられる。
Furthermore, as a lower alkylamide group, an acetamide group,! Examples include linear or branched chains having 1 to 6 carbon atoms such as ropionamide group and n-butylamide group.

なお、上述した(1)式に示す化学構造式を有する本発
明化合物を具体的に例示すると第1表に示す通9である
A specific example of the compound of the present invention having the chemical structural formula shown in formula (1) above is compound 9 shown in Table 1.

第1表 前記(1)式の化合物は、5−・・ログノフェニルー1
−フェニル−IH−ピラゾロ(3,4−b 〕ピラジン
等に対し、該当するフェノール誘導体を反応させること
により合成することができる(下記反応式a参照)。
Table 1 The compound of formula (1) above is 5-...lognophenyl-1
It can be synthesized by reacting -phenyl-IH-pyrazolo(3,4-b) pyrazine or the like with a corresponding phenol derivative (see reaction formula a below).

(1) (但し、Xはハロゲン原子、−SO2−R基、−NO2
基又は−CN基を示す。なお、Rはアルキル基、フェ=
 # 基又i、iアルキルフェニル基に示す。) なお、(2)式においてXがクロル原子である5−クロ
ロ−1−フェニル−IH−ピラゾロ(3,4−b〕ビラ
ジ/(式(2’))は、下記反応式すにその一例を示す
ように、(3ン式の5−アミノ−1−フェニル−ピラゾ
ール−4−カル?ン酸を例えば180℃に加熱して脱炭
[−行ない、(4)式の5−アミノ−1−2エニルービ
ラゾールを合成し、これを乾燥塩酸存在下エタノール中
で亜硝酸イソアミルと反応さ−♂て(5)式の5−アミ
ノ−4−ニトロノー1−フェニル−ビラゾール塩酸塩を
得た後、これ全・母うノウム炭素を用いて接触還元する
ことにより(6)式の4,5−ジアミン−1−フェニル
−ピラゾールを合成し、次いでこれを水中でダリオキ/
ル酸と反応させて(7)式の4.5−ジヒドロ−1−フ
ェニル−IH−ピラゾロ(3,4−b )ピラジン−5
−オン?合成し、最後にこれをオキシ塩化リンと還流す
ることにより得ることができる。
(1) (However, X is a halogen atom, -SO2-R group, -NO2
group or -CN group. Note that R is an alkyl group,
# Also shown in group i, i alkylphenyl group. ) In addition, 5-chloro-1-phenyl-IH-pyrazolo(3,4-b]biraj/(formula (2')) in which X is a chloro atom in formula (2) is an example of the following reaction formula. As shown, 5-amino-1-phenyl-pyrazole-4-caranoic acid of formula (3) is heated to, for example, 180°C to decarburize [-, -2-enyl-virazole was synthesized and reacted with isoamyl nitrite in ethanol in the presence of dry hydrochloric acid to obtain 5-amino-4-nitrono-1-phenyl-virazole hydrochloride of formula (5). After that, 4,5-diamine-1-phenyl-pyrazole of formula (6) was synthesized by catalytic reduction using total mother carbon, and then this was catalytically reduced using Darioki/Pyrazole in water.
4,5-dihydro-1-phenyl-IH-pyrazolo(3,4-b)pyrazine-5 of formula (7)
-On? It can be obtained by synthesis and finally refluxing this with phosphorus oxychloride.

(6)             (7)前記(1)式
の化合物は、優れた抗腫瘍作用を有し、癌化細胞の増殖
を抑制するため、抗腫瘍剤として有効に使用される。
(6) (7) The compound of formula (1) has an excellent antitumor effect and suppresses the proliferation of cancerous cells, and is therefore effectively used as an antitumor agent.

(9) 以下、本発明化合物(1)の製造例を具体的に示す。(9) Hereinafter, a production example of the compound (1) of the present invention will be specifically shown.

〔製造例1〕 フェノール5.09 (0,053モル)に水酸化ナト
リウム0.34 g(0,0085モル)を浴がし、こ
れに5−クロロ−1−フェニル−I H−e’ノゾロ[
3,4−b )ピラノンt o o 9 (0,o04
3モル)を加え、150℃で2時間反応させた後、反応
混合物をクロロホルムに溶解する。これ全10%水酸化
ナトリウムで洗浄し、乾燥後、溶媒を留去する。残渣金
ベンゼンーヘキサン混合溶媒で再結晶し、無色針状結晶
の5−フェニルオキシ−1−フヱニルーIH−ピラゾロ
[3,4−b 〕ピラノン1、20 g(収率92チ)
を得た・ 〔製造例2〕 p−プロモフ□ノール2.00 g (0,0115モ
ル)及び水酸化カリウム0.5 、j9 (0,009
モル) iDMs03 mlに溶かし、これに5−クロ
ロ−1−フェニル−1)1−ピラノ0 [3,4−b 
]ピラノ71.00ji(0,0043モル)を加え、
100℃で2時間反応させる。以下、実施例1と同様に
操作し、残渣をヘキサンで再結晶して無色鱗片状結晶の
5−(4−プロモフエニルオキノ)−1−フェニル−I
H−ビラゾロC3,4−b )ピラジン1.41g(収
率89%)を得た。
[Production Example 1] 0.34 g (0,0085 mol) of sodium hydroxide was bathed in 5.09 (0,053 mol) of phenol, and 5-chloro-1-phenyl-I H-e' [
3,4-b) Pyranone too9 (0,o04
After reacting at 150° C. for 2 hours, the reaction mixture is dissolved in chloroform. This was washed with 10% sodium hydroxide, dried, and the solvent was distilled off. The residual gold was recrystallized from a benzene-hexane mixed solvent to give colorless needle-like crystals of 5-phenyloxy-1-phenyl-IH-pyrazolo[3,4-b]pyranone 1.20 g (yield: 92 cm).
[Production Example 2] 2.00 g (0,0115 mol) of p-promophenol and 0.5 g (0,009 mol) of potassium hydroxide
5-chloro-1-phenyl-1) 1-pyrano [3,4-b
] Pyrano 71.00ji (0,0043 mol) was added,
React at 100°C for 2 hours. The following procedure was repeated in the same manner as in Example 1, and the residue was recrystallized from hexane to obtain colorless scaly crystals of 5-(4-promophenylokino)-1-phenyl-I.
1.41 g (yield: 89%) of H-VirazoloC3,4-b) pyrazine was obtained.

〔製造例3〜11〕 第2表に示す各フェノール誘導体を用い、実施例2と同
様の操作を行ない、残渣を第2表に示す再結晶溶媒を用
いて再結晶し、第2表に示す目的化合物を得た。
[Production Examples 3 to 11] Using each phenol derivative shown in Table 2, the same operation as in Example 2 was performed, and the residue was recrystallized using the recrystallization solvent shown in Table 2. The target compound was obtained.

なお、製造例1〜11の目的化合物の形状、融点、IR
全第2表に示す。
In addition, the shape, melting point, IR of the target compounds of Production Examples 1 to 11
All shown in Table 2.

Claims (1)

【特許請求の範囲】 下記式 (但し、Rはフェニル基又はその水素原子の1又は2以
上金ハロゲン原子、水酸基、低級アルキル基、低級アル
コキシ基、アミン基もしくは低級アルキルアミド基によ
り置換されたフェニル基金示す。) で示される5−フェニルオキシ−1−フェニル−IH−
ピラゾロC3,4−b 〕ピラノン誘導体。
[Scope of Claims] The following formula (where R is a phenyl group, or phenyl substituted with one or more of its hydrogen atoms by a gold halide atom, a hydroxyl group, a lower alkyl group, a lower alkoxy group, an amine group, or a lower alkylamide group) 5-phenyloxy-1-phenyl-IH-
PyrazoloC3,4-b] Pyranone derivative.
JP6367682A 1982-02-05 1982-04-16 5-phenyloxy-1-phenyl-1h-pyrazolo(3,4-b)pyrazine derivative Pending JPS58180486A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP6367682A JPS58180486A (en) 1982-04-16 1982-04-16 5-phenyloxy-1-phenyl-1h-pyrazolo(3,4-b)pyrazine derivative
US06/428,016 US4460773A (en) 1982-02-05 1982-09-29 1-Phenyl-1H-pyrazolo [3,4-b]pyrazine derivatives and process for preparing same
DE19823237243 DE3237243A1 (en) 1982-02-05 1982-10-07 1-PHENYL-1H-PYRAZOLO (3,4-B) PYRAZINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6367682A JPS58180486A (en) 1982-04-16 1982-04-16 5-phenyloxy-1-phenyl-1h-pyrazolo(3,4-b)pyrazine derivative

Publications (1)

Publication Number Publication Date
JPS58180486A true JPS58180486A (en) 1983-10-21

Family

ID=13236194

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6367682A Pending JPS58180486A (en) 1982-02-05 1982-04-16 5-phenyloxy-1-phenyl-1h-pyrazolo(3,4-b)pyrazine derivative

Country Status (1)

Country Link
JP (1) JPS58180486A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6317882A (en) * 1986-07-09 1988-01-25 Lion Corp 5-substituted-1h-pyrazolo(3,4-b)pyrazine derivative and antitumor agent containing said compound

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6317882A (en) * 1986-07-09 1988-01-25 Lion Corp 5-substituted-1h-pyrazolo(3,4-b)pyrazine derivative and antitumor agent containing said compound

Similar Documents

Publication Publication Date Title
HUE024989T2 (en) Derivatives of azaindoles as inhibitors of protein kinases abl and src
JPS5848545B2 (en) Shinki Hōkōzoku Carbon Sanamide Yudōtai no Seizō Hōhō
JPS58180486A (en) 5-phenyloxy-1-phenyl-1h-pyrazolo(3,4-b)pyrazine derivative
JPS634543B2 (en)
JP2018150293A (en) Caged compound and method for producing the same
JPS58180485A (en) 5-phenylamino-1-phenyl-1h-pyrazolo(3,4-b)pyrazine derivative
JPH061776A (en) Production of substituted pyrazinecarbonitrile
JPS5944313B2 (en) Manufacturing method of indazole derivatives
US3172908A (en) Derivatives of j-methylvaleric acids
Mabkhot et al. SPONTANEOUS α‐METHYLATION OF AN α-BROMOKETONE FROM DMF: SYNTHESIS AND CRYSTALLINE STRUCTURE OF 1, 1'-(3, 4-DIPHENYLTHIENO [2, 3-b] THIOPHENE-2, 5-DIYL) BIS (PROPAN-1-ONE)
WO2024126771A1 (en) Process for preparing (z)-3-(2-(5-bromo-1h-indol-3-yl)-2-cyanovinyl)-4-methoxybenzonitrile
JPS6045626B2 (en) Novel 1,2,3,4-tetrahydronaphthalene derivative
US20040132982A1 (en) Process for the preparation of aromatic azo-compounds
JPH0673058A (en) 5-deazaflavin derivative and its production
JPS6317850A (en) Production of 3-phenoxycatechols
JPS6019314B2 (en) 2,3,6,7↓-tetrahydro↓-3↓-oxo↓-5H↓-pyridazino[3,4↓-b][1,4]oxazine derivative
WO2021142420A1 (en) PYRAZOLO[1,5-a]PYRIMIDIN-7(4H)-ONE INHIBITORS OF DYNEIN
JPH03170460A (en) Preparation of alkylenebis (2-pyridylamine) compound
JPS58135887A (en) 1-phenyl-1h-pyrazolo(3,4-b)pyrazine derivative
JPS5942677B2 (en) 100% free of charge
JPS58134094A (en) 3-formyl-pyrazolo(1,5-b)pyridazine derivative and preparation thereof
JPH01242537A (en) Production of 2-fluorobiphenyl derivative
JPS6130660B2 (en)
JPS596878B2 (en) Piroro (1,2-A) Indian-Ruinoseizouhou
JPS63222141A (en) Production of adamantoyl-substituted olefins